OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-04-30-accounts

REGISTERED CHARITY NUMBER: 505256

Report of the Trustees and

Unaudited Financial Statements for the Year Ended 30 April 2023

for

Kidneys For Life

Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB

Kidneys For Life

Contents of the Financial Statements for the Year Ended 30 April 2023

Page
Report of the Trustees 1 to 5
Independent Examiner's Report 6
Statement of Financial Activities 7
Balance Sheet 8 to 9
Notes to the Financial Statements 10 to 21
Detailed Statement of Financial Activities 22 to 23

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2023

The trustees present their report with the financial statements of the charity for the year ended 30 April 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES

Our mission

The strategic aim of Kidneys for Life fundraising for MINT (Manchester Institute for Nephrology & Transplantation) is the relief of renal related illnesses and the funding of research and education in renal disease, transplantation and allied fields together with the provision of direct patient amenities.

Objectives

Kidneys for Life's objectives and main activities are to undertake charitable fundraising and the provision of those funds for the research and education in renal disease and allied fields and the provision of direct patient amenities.

The trustees confirm that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the Trust's aims and objectives and in planning future activities and setting the grant making policy for the year.

Significant activities

The main activities currently carried out for the public benefit by the charity can be broadly categorised into the following:-

The beneficiaries of our main activities are ultimately sufferers of renal related diseases and those at risk of developing this disease in the future together with their families/carers. There are increasing numbers of people in the UK with some form of kidney disease and this is on the rise due to increased life expectancy and less healthier lifestyles. Developments in the care and treatment of those suffering from kidney disease has also the potential to relieve the huge burden of care often faced by the families and/or carers of sufferers. Our research and educational programmes funds researchers and renal staff who use these funds in their work to improve the lives of sufferers from kidney disease and related conditions, and their carers by developing therapies, potential medications and improvements in the personal care of sufferers. Any benefit received by researchers is purely incidental to the objects of our work.

MINT is a member of the Association of Medical Research Charities and follows best practice in maintaining the independence of research funding and ensuring that sponsored researchers abide by best practice in research ethics and animal testing; our aim is to maximise the efficiency of the research programme whilst minimising the likelihood of harm to research volunteers and animals.

How we work

The charity delivers its main aims in a number of ways including:-

Academic ability and research potential are the primary determinants of our bursaries and grants and other factors such as nationality, ethnicity, gender, age, disability, sexual orientation and religion will not be taken into account.

Page 1

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2023

OBJECTIVES AND ACTIVITIES

In addition to this the charity also funds direct patient amenities for those suffering from renal disease or related diseases and this provision is not dependent upon factors such as nationality, ethnicity, gender, age, disability, sexual orientation and religion.

ACHIEVEMENT AND PERFORMANCE Review of our achievements this financial year

The benefits of the charities work is the research into renal related diseases, education of renal staff, the dissemination of research findings, the development of new therapies and the funding of on-going research with the goal being to assist sufferers of renal related diseases, their carers and families. The trustees are pleased that the achievements and performance of the Charity as set out below with more detail on expenditure items, demonstrate our commitment to relieving the suffering of those with renal related diseases:-

More information of our research projects and researchers can be found on our website.

Page 2

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2023

FINANCIAL REVIEW

Results

The total incoming resources for the year amount to £308,130 (2022 - £203,991). The charity expenditure for the financial year was £292,025 (2022 - £168,536).

The current market value of the KFL investment portfolio at the year end was £263,357. Although there has been a reduction in the investments held the balance of the investment portfolio continues to recover, the market value of investments at the previous year end was £290,601.

The event calendar for this financial year has been full as we were finally in a position to run the events that had been postponed during the various Covid-19 lockdowns. These events were financially successful and in addition to generating much-needed funds for Kidneys for Life, they also gave us a platform to share our work to a wide and varied audience.

We were also beneficiaries of two generous donations made by the families of deceased patients.

Whilst the balance of the investment portfolio is lower than at the same point in 2022, we realise this is a result of the global economic climate; we have no immediate plans to withdraw any funds from these investments.

We have been pleased with the income generated in this financial year and look forward to another successful year, nonetheless mindful that the cost of living crisis may affect our donations in this coming year.

Investment policy and financial position

The charity has the power to make any investment which the Trustees see fit. Our investments are managed by Redmayne Bailey and we receive quarterly reports on the value of the Kidneys for Life portfolio. The spread of investments was agreed and a certain approach to risk continued. The charity believes it can generate income which together with investment income will allow the charity to continue for the foreseeable future with its level of charitable payments.

Reserves policy

The events of recent years have had an effect upon the reserves of the Charity and the Trustees are aware that it will be imperative that we maintain income to ensure that we are able to have in reserves funding for one year for our Travel Bursaries, Nurse Education Grants, Publication Grants & Small Research Grants Scheme, £200k approximately. We endeavour to spend in excess of our income, save for restricted funds as detailed in Note 14, leaving sufficient reserves to fund ongoing research as mentioned.

FUTURE PLANS

We will continue to carry out our main activities and our focus on future research, which by its nature is a slow process. Our focus will be:

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document and legal status

The trust is governed by a trust deed dated 6th May 1976 and supplemental deeds of 15th September 1977 and 1st September 1983 and resolution of 4th August 1997, with the scheme further amended on 10th May 2000, 12 July 2007, 11th December 2015, 19th July 2019 and 22nd November 2019.

Recruitment and appointment of new trustees

A trustee can propose the appointment of a trustee, on a proposal a vote shall be taken and approval shall be obtained through a simple majority.

Page 3

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT

Organisation

The charity is administered from the Renal Unit at Manchester Royal Infirmary. The charity's objects and principal activity consists of charitable fundraising and the provisions of those funds for the advancement of research and provision of direct patient amenities for those suffering from kidney related diseases.

Our trustees are unpaid and details of trustee expenses and any related party transactions are disclosed in note 5 to the accounts.

Decision making

All decisions are made by a consensus of the Trustees who are all Renal Consultants in the North-West of England.

Trustee induction, training and development

New trustees are provided with an induction pack and are given initial training by the trustees and further training as and when required.

Risk management

The Trustees review the major risks which the Charity faces at Trustee meetings. Trustee meetings take place on a quarterly basis and will continue to do so going forward. In addition to this the Trustees will convene additional meetings to discuss the financial position of the Charity. It is anticipated that by reviewing on a regular basis the Trustees will be able to appropriately adjust the reserves and charitable payments in line with the performance of the Charity. This will allow for the Trustees to provide sufficient resources in the event of adverse conditions. The Trustees have also examined other operational and business risks faced by the Charity and confirm that they have established systems to mitigate the immediate significant risks.

REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number

505256

Principal address

Renal Unit Manchester Royal Infirmary Oxford Road Manchester M13 9WL

Trustees

Trustees
Professor Titus Augustine Consultant Surgeon Resigned 19th May 2023
Professor Rachel Lennon Consultant Paediatric Physician
Professor Sandip Mitra Consultant Physician
Mr Afshin Tavakoli Consultant Surgeon
Professor Phil Kalra Consultant Physician
Dr Durga Kanigicherla Consultant Nephrologist
Dr Amrit Kaur Consultant in Paediatric Nephrology
Professor Smeeta Sinha Consultant Nephrologist
Dr Michael Picton Consultant Renal Physician Resigned 6th January 2023
Dr Andrew Nixon Consultant Nephrologist Appointed 19th May 2023
Dr Ajay Dhaygude Consultant Renal Physician Appointed 19th May 2023

Page 4

Kidneys For Life

Report of the Trustees for the Year Ended 30 April 2023

REFERENCE AND ADMINISTRATIVE DETAILS Independent Examiner Paul Scriven FCCA Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB

Approved by order of the board of trustees on 19 January 2024 and signed on its behalf by:

Mr Afshin Tavakoli - Trustee

Page 5

Independent Examiner's Report to the Trustees of Kidneys For Life

Independent examiner's report to the trustees of Kidneys For Life

I report to the charity trustees on my examination of the accounts of Kidneys For Life (the Trust) for the year ended 30 April 2023.

Responsibilities and basis of report

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').

I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.

Independent examiner's statement

Since your charity's gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a member of the Association of Chartered Certified Accountants, which is one of the listed bodies.

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Paul Scriven FCCA

Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB

19 January 2024

Page 6

Kidneys For Life

Statement of Financial Activities

for the Year Ended 30 April 2023

Unrestricted
funds
Notes
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
2
122,112
Other trading activities
3
144,752
Investment income
4
3,236
Other income
633
Total
270,733
EXPENDITURE ON
Raising funds
121,406
Charitable activities
Expenditure on Charitable Activities
77,649
Total
199,055
Net gains/(losses) on investments
(26,170)
NET INCOME/(EXPENDITURE)
45,508
Transfers between funds
14
(36,789)
Net movement in funds
8,719
RECONCILIATION OF FUNDS
Total funds brought forward
92,540
TOTAL FUNDS CARRIED FORWARD
101,259		 Restricted
funds
£
16,665
19,880
2
850
37,397
9,953
83,017
92,970
-
(55,573)
36,789
(18,784)
247,461
228,677		 30.4.23
Total
funds
£
138,777
164,632
3,238
1,483
308,130
131,359
160,666
292,025
(26,170)
(10,065)
-
(10,065)
340,001
329,936		 30.4.22
Total
funds
£
101,774
99,764
2,453
-
203,991
62,611
105,925
168,536
(9,431)
26,024
-
26,024
313,977
340,001

CONTINUING OPERATIONS

All income and expenditure has arisen from continuing activities.

The notes form part of these financial statements

Page 7

Kidneys For Life

Balance Sheet 30 April 2023

Unrestricted
funds
Notes
£
FIXED ASSETS
Investments
10
127,857
CURRENT ASSETS
Stocks
11
3,274
Debtors
12
7,245
Cash at bank and in hand
25,939
36,458
CREDITORS
Amounts falling due within one year
13
(63,056)
NET CURRENT ASSETS
(26,598)
TOTAL ASSETS LESS CURRENT
LIABILITIES
101,259
NET ASSETS
101,259		 Restricted
funds
£
135,500
-
-
93,277
93,277
(100)
93,177
228,677
228,677		 30.4.23
Total
funds
£
263,357
3,274
7,245
119,216
129,735
(63,156)
66,579
329,936
329,936		 30.4.22
Total
funds
£
290,601
1,496
4,066
142,400
147,962
(98,562)
49,400
340,001
340,001

The notes form part of these financial statements

continued...

Page 8

Kidneys For Life

Balance Sheet - continued 30 April 2023

FUNDS
14
Unrestricted funds:
General fund
Revaluation Fund
Restricted funds:
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney Information
network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
TOTAL FUNDS		 88,468
12,791
101,259
59,966
19,970
135,500
287
4,642
4,007
-
1,998
845
935
527
228,677
329,936		 53,260
39,280
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
-
-
247,461
340,001

The financial statements were approved by the Board of Trustees and authorised for issue on 19 January 2024 and were signed on its behalf by:

Mr Afshin Tavakoli - Trustee

Dr Amrit Kaur - Trustee

The notes form part of these financial statements

Page 9

Kidneys For Life

Notes to the Financial Statements for the Year Ended 30 April 2023

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.

Financial reporting standard 102 - reduced disclosure exemptions

The charity has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.The following specific policies are applied to particular categories of income:

Voluntary income is received by way of grants, donations and gifts and is included in full in the statement of financial activities when receivable. Grants, where entitlement is not conditional on the delivery of a specific performance by the charity are recognised when the charity becomes unconditionally entitled to the grant.

Investment income is included when receivable.

Fundraising events income includes all income from both Kidneys for Life led events and those undertaken by supporters.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Expenditure includes any irrecoverable VAT which cannot be fully recovered and is charged against the expenditure to which it relates. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Cost of raising funds comprise of the costs associated with attracting voluntary income and the costs of trading for fundraising purposes.

Charitable expenditure comprise of those costs incurred by the charity in the delivering of its activities and providing grants.

Governance costs include those costs associated with the constitutional and statutory requirements of the Charity and include the accountancy fee and other overhead and support costs.

Tangible fixed assets

Fixed assets (excluding investments) are stated at cost less accumulated depreciation. The costs of minor additions or those costing below £1,000 are not capitalised. Depreciation is provided at rates calculated to write off the cost of each asset over its expected useful life, which in all cases is estimated at 5 years.

continued...

Page 10

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

1. ACCOUNTING POLICIES - continued

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Unrestricted funds include a revaluation reserve representing the restatement of investment assets at current value.

Designated funds are unrestricted funds earmarked by the management committee for particular purposes.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or through the terms of an appeal.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits

The Charity operates a defined contribution pension scheme. Contributions payable to the pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

2. DONATIONS AND LEGACIES

Donations
Grants		 30.4.23
£
134,150
4,627
138,777		 30.4.22
£
101,774
-
101,774

Donations includes £12,038 (2022 - £22,238) relating to the restricted funds for Bladder Exstrophy, Children's Renal Fund (formerly Child Transplant Games), Tameside Dialysis, CAMKIN and Altrincham Dialysis.

Grants received, included in the above, are as follows:

30.4.23 30.4.22
£ £
Other grants 4,627 -

continued...

Page 11

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

3. OTHER TRADING ACTIVITIES

OTHER TRADING ACTIVITIES
30.4.23 30.4.22
£ £
Fundraising events 164,632 99,764

Fundraising includes £19,880 (2022 - £32,609) relating to the restricted funds for Children's Renal Fund (formerly Child Transplant Games), Bladder Exstrophy, Tameside Dialysis and bladder Exstrophy Xmas Party.

4. INVESTMENT INCOME

INVESTMENT INCOME
30.4.23 30.4.22
£ £
Dividend and stock income 2,720 2,437
Deposit account interest 518 16
3,238 2,453

5.

TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 30 April 2023 nor for the year ended 30 April 2022.

Trustees' expenses

There were no trustees' expenses paid or travel bursaries awarded during the year ended 30 April 2023 nor for the year ended 30 April 2022.

6. STAFF COSTS

The average monthly number of employees during the year was as follows:

7.

Staff
No employees received emoluments in excess of £60,000.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
funds
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
79,536
Other trading activities
67,155
Investment income
2,453
Total
149,144
EXPENDITURE ON
Raising funds
62,590
Charitable activities
Expenditure on Charitable Activities
68,292		 30.4.23

1
Restricted
funds
£
22,238
32,609
-
54,847
21
37,633		 30.4.22
1
Total
funds
£
101,774
99,764
2,453
203,991
62,611
105,925

continued...

Page 12

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Total
130,882
37,654
Net gains/(losses) on investments
(9,431)
-
NET INCOME
8,831
17,193
Transfers between funds
(55,929)
55,929
Net movement in funds
(47,098)
73,122
RECONCILIATION OF FUNDS
Total funds brought forward
139,638
174,339
TOTAL FUNDS CARRIED FORWARD
92,540
247,461
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.23
£
Share dealing - gains
1,346
Share dealing - losses
(1,027)
319
Unrealised (loss)/gain on revaluation
(26,489)
(26,170)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
70
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2022 and 30 April 2023
1,518
13,535
DEPRECIATION
At 1 May 2022 and 30 April 2023
1,518
13,535
NET BOOK VALUE
At 30 April 2023
-
-
At 30 April 2022
-
-		 7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Total
130,882
37,654
Net gains/(losses) on investments
(9,431)
-
NET INCOME
8,831
17,193
Transfers between funds
(55,929)
55,929
Net movement in funds
(47,098)
73,122
RECONCILIATION OF FUNDS
Total funds brought forward
139,638
174,339
TOTAL FUNDS CARRIED FORWARD
92,540
247,461
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.23
£
Share dealing - gains
1,346
Share dealing - losses
(1,027)
319
Unrealised (loss)/gain on revaluation
(26,489)
(26,170)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
70
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2022 and 30 April 2023
1,518
13,535
DEPRECIATION
At 1 May 2022 and 30 April 2023
1,518
13,535
NET BOOK VALUE
At 30 April 2023
-
-
At 30 April 2022
-
-		 7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Total
130,882
37,654
Net gains/(losses) on investments
(9,431)
-
NET INCOME
8,831
17,193
Transfers between funds
(55,929)
55,929
Net movement in funds
(47,098)
73,122
RECONCILIATION OF FUNDS
Total funds brought forward
139,638
174,339
TOTAL FUNDS CARRIED FORWARD
92,540
247,461
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.23
£
Share dealing - gains
1,346
Share dealing - losses
(1,027)
319
Unrealised (loss)/gain on revaluation
(26,489)
(26,170)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
70
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2022 and 30 April 2023
1,518
13,535
DEPRECIATION
At 1 May 2022 and 30 April 2023
1,518
13,535
NET BOOK VALUE
At 30 April 2023
-
-
At 30 April 2022
-
-		 7.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted
Restricted
funds
funds
£
£
Total
130,882
37,654
Net gains/(losses) on investments
(9,431)
-
NET INCOME
8,831
17,193
Transfers between funds
(55,929)
55,929
Net movement in funds
(47,098)
73,122
RECONCILIATION OF FUNDS
Total funds brought forward
139,638
174,339
TOTAL FUNDS CARRIED FORWARD
92,540
247,461
8.
NET GAINS/(LOSSES) ON INVESTMENTS
Realised net gains on investments
30.4.23
£
Share dealing - gains
1,346
Share dealing - losses
(1,027)
319
Unrealised (loss)/gain on revaluation
(26,489)
(26,170)
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
70
9.
TANGIBLE FIXED ASSETS
Office
Computer
equipment
equipment
£
£
COST
At 1 May 2022 and 30 April 2023
1,518
13,535
DEPRECIATION
At 1 May 2022 and 30 April 2023
1,518
13,535
NET BOOK VALUE
At 30 April 2023
-
-
At 30 April 2022
-
-		 Total
funds
£
168,536
(9,431)
26,024
-
26,024
313,977
340,001
30.4.22
£
307
-
307
(9,738)
(9,431)
£
120
Totals
£
15,053
15,053
-
-
30.4.23
£
1,346
(1,027)
319
(26,489)
(26,170)
£
70
Computer
equipment
£
13,535
13,535
-
-

continued...

Page 13

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

10. FIXED ASSET INVESTMENTS

Fixed asset investments consist of the Kidneys for Life Portfolio. The Portfolio is valued at current market value at the year end date

11. STOCKS

11. STOCKS
30.4.23 30.4.22
£ £
Finished goods 3,274 1,496
12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.23 30.4.22
£ £
Trade debtors 633 -
Other debtors 4,722 2,543
Provision for tax rebate - 470
Prepayments 1,890 1,053
7,245 4,066
13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.23 30.4.22
£ £
Trade creditors 2,641 56,973
Taxation and social security 96 (28)
Other creditors 60,419 41,617
63,156 98,562

continued...

Page 14

Kidneys For Life

Notes to the Financial Statements - continued

for the Year Ended 30 April 2023

14. MOVEMENT IN FUNDS

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
TOTAL FUNDS		 At 1.5.22
£
53,260
39,280
-
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
-
-
247,461
340,001		 Net
movement
in funds
£
83,841
(26,489)
(11,844)
45,508
(9,105)
355
(50,705)
2
850
2,905
(1,000)
-
500
935
(310)
(55,573)
(10,065)		 Transfers
between
funds
£
(48,633)
-
11,844
(36,789)
-
(837)
36,789
-
-
-
-
-
-
-
837
36,789
-		 At
30.4.23
£
88,468
12,791
-
101,259
59,966
19,970
135,500
287
4,642
4,007
-
1,998
845
935
527
228,677
329,936

Page 15

continued...

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

14. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
TOTAL FUNDS		 Incoming
resources
£
270,733
-
-
270,733
28,103
4,059
-
2
850
2,905
-
500
935
43
37,397
308,130		 Resources
expended
£
(187,211)
-
(11,844)
(199,055)
(37,208)
(3,704)
(50,705)
-
-
-
(1,000)
-
-
(353)
(92,970)
(292,025)		 Gains and
Movement
losses
in funds
£
£
319
83,841
(26,489)
(26,489)
-
(11,844)
(26,170)
45,508
-
(9,105)
-
355
-
(50,705)
-
2
-
850
-
2,905
-
(1,000)
-
500
-
935
-
(310)
-
(55,573)
(26,170)
(10,065)

Page 16

continued...

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

14. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
TOTAL FUNDS		 At 1.5.21
£
90,620
49,018
-
139,638
36,443
3,427
126,292
285
3,792
1,102
1,000
1,998
-
174,339
313,977		 Net
movement
in funds
£
34,183
(9,738)
(15,614)
8,831
32,628
17,025
(32,805)
-
-
-
-
-
345
17,193
26,024		 Transfers
between
funds
£
(71,543)
-
15,614
(55,929)
-
-
55,929
-
-
-
-
-
-
55,929
-		 At
30.4.22
£
53,260
39,280
-
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
247,461
340,001

Comparative net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Cheshire and Merseyside Kidney
Information network Recipe
TOTAL FUNDS		 Incoming
resources
£
149,144
-
-
149,144
34,908
19,594
-
345
54,847
203,991		 Resources
expended
£
(115,268)
-
(15,614)
(130,882)
(2,280)
(2,569)
(32,805)
-
(37,654)
(168,536)		 Gains and
Movement
losses
in funds
£
£
307
34,183
(9,738)
(9,738)
-
(15,614)
(9,431)
8,831
-
32,628
-
17,025
-
(32,805)
-
345
-
17,193
(9,431)
26,024		 Gains and
Movement
losses
in funds
£
£
307
34,183
(9,738)
(9,738)
-
(15,614)
(9,431)
8,831
-
32,628
-
17,025
-
(32,805)
-
345
-
17,193
(9,431)
26,024
8,831
32,628
17,025
(32,805)
345
17,193
26,024

continued...

Page 17

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

14. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
TOTAL FUNDS		 At 1.5.21
£
90,620
49,018
-
139,638
36,443
3,427
126,292
285
3,792
1,102
1,000
1,998
-
-
-
174,339
313,977		 Net
movement
in funds
£
118,024
(36,227)
(27,458)
54,339
23,523
17,380
(83,510)
2
850
2,905
(1,000)
-
845
935
(310)
(38,380)
15,959		 Transfers
between
funds
£
(120,176)
-
27,458
(92,718)
-
(837)
92,718
-
-
-
-
-
-
-
837
92,718
-		 At
30.4.23
£
88,468
12,791
-
101,259
59,966
19,970
135,500
287
4,642
4,007
-
1,998
845
935
527
228,677
329,936

continued...

Page 18

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

14. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Revaluation Fund
Designated Fund
Restricted funds
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
TOTAL FUNDS
Purpose of funds		 Incoming
resources
£
419,877
-
-
419,877
63,011
23,653
-
2
850
2,905
-
845
935
43
92,244
512,121		 Resources
expended
£
(302,479)
-
(27,458)
(329,937)
(39,488)
(6,273)
(83,510)
-
-
-
(1,000)
-
-
(353)
(130,624)
(460,561)		 Gains and
Movement
losses
in funds
£
£
626
118,024
(36,227)
(36,227)
-
(27,458)
(35,601)
54,339
-
23,523
-
17,380
-
(83,510)
-
2
-
850
-
2,905
-
(1,000)
-
845
-
935
-
(310)
-
(38,380)
(35,601)
15,959

Designated Fund

The purpose of the designated funds is to provide for travel bursaries, upkeep of the renal library, small grants scheme and educational grants for renal staff and direct patient amenities.

Revaluation Fund

The revaluation fund recognises the amount by which the investments exceed their historical cost.

Bladder Exstrophy Fund

This fund is for use by the Bladder Exstrophy Team at Royal Manchester Children's Hospital to facilitate their annual Christmas Party, medical equipment and research funding.

Children's Renal Fund (formerly Child Transplant Games)

This fund is for use by the Children's Renal Team at Royal Manchester Children's Hospital to facilitate the attendance of the Manchester Children's Transplant Games Team at the British Transplant Games each year, purchase of medical equipment, patient amenities for the wards and staff education.

Kidney Info Network

We work with GMKIN (Greater Manchester Kidney Information Network) to provide a social media presence for kidney patients in the North West. The fund is for use in maintaining this presence.

continued...

Page 19

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

14. MOVEMENT IN FUNDS - continued

Purpose of funds - continued

Tameside Dialysis Fund

Kidneys for Life received a donation in memory of a Tameside Dialysis patient and with the request that these funds be spent at Tameside Dialysis Unit. The staff at the Unit are aware of this donation and will communicate with Kidneys for Life when they decide how they would like this money to be spent.

Urology Sports Day Fund

The Urology Sports Day was set up by Dr Anju Goyal and was paid for using funds from the Urology Fund which Kidneys for Life administers as per the MOU on their behalf. It is to be used to facilitate an annual event.

Adult Games Fund

Kidneys for Life received a donation with the request that these funds be spent on adult games.

Polycystic Kidney Disease Research Fund

Kidneys for Life received a donation with the request that these funds be spent on polycystic kidney disease research.

Cheshire and Merseyside Kidney Information Network Recipe Fund Received donations to fund a special renal recipe book.

Altrincham Dialysis Fund

Kidneys for Life received a donation in memory of an Altrincham Dialysis patient and with the request that these funds be spent at this Unit. The staff at this Unit are aware of this donation and will communicate with Kidneys for Life when they decide how they would like this money to be spent.

Bladder Exstrophy Xmas Party Fund

This is an annual event organised by the parents of the Bladder Ex fund. Kidneys for Life supports the parents in the organisation of this event. The money in this fund is used to pay for the party to take place.

15. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 30 April 2023 and none for the year ended 30 April 2022, except for a transaction of £350 with a company that Professor Phil Kalra is a member of and has a position of control/management.

All trustees remove themselves from any decision if they have a related party connection with the company being discussed.

16. FABRY NEPHROPATHY CONFERENCE FUND

A separate bank account was opened to facilitate the income and expenditure for the bi-annual conference. The next conference is scheduled to take place in Hamburg in 2024. The movement on the account is shown below. The end balance equating to the balance on the bank account at the 30th April 2023.

Balance at Balance at
1.5.22 Incoming Outgoing 30.4.23
£ £ £ £
Movement to date 238,082 68,133 153,072 153,143

The Fabry bank account owed £4,527 to Kidneys for life at the 30th April 2023.

continued...

Page 20

Kidneys For Life

Notes to the Financial Statements - continued for the Year Ended 30 April 2023

16. FABRY NEPHROPATHY CONFERENCE FUND - continued

The SCFUG, with Professor David Warnock and Professor Stephen Waldek at the helm, ensure there are sufficient funds available before expenditure is approved ensuring there is never a shortfall of funds. They have now stated that all decisions relating to travel bursaries are not to be made until the committee meets in January 2024. This gives sufficient time to amend the program to fit within the budget.

Page 21

Kidneys For Life

Detailed Statement of Financial Activities
for the Year Ended 30 April 2023
30.4.23 30.4.22
£ £
INCOME AND ENDOWMENTS
Donations and legacies
Donations 134,150 101,774
Grants 4,627 -
138,777 101,774
Other trading activities
Fundraising events 164,632 99,764
Investment income
Dividend and stock income 2,720 2,437
Deposit account interest 518 16
3,238 2,453
Other income
Other income 1,483 -
Total incoming resources 308,130 203,991
EXPENDITURE
Raising donations and legacies
Wages 38,280 34,190
Postage and miscellaneous 1,826 2,069
Promotional costs 14,269 10,600
Event costs 72,437 12,478
Travel costs 1,010 74
Card fees 906 1,062
Christmas cards 2,631 2,138
131,359 62,611
Charitable activities
Grant management 17,808 17,304
Bladder Exstrophy Fund 1,947 2,345
Children's Renal Fund (formerly Childrens
Transplant Games) 27,195 -
Miscellaneous grants 8,513 13,340
Ward and medical equipment 1,254 118
Travel & conference bursaries 2,574 1,213
Small research grants 50,705 32,805
Nurse education 2,054 300
Patient support 7,756 2,426
Publication grants 500 700
120,306 70,551

This page does not form part of the statutory financial statements

Page 22

Kidneys For Life

Detailed Statement of Financial Activities

Detailed Statement of Financial Activities
for the Year Ended 30 April 2023
30.4.23 30.4.22
£ £
Support costs
Governance costs
Governance management 12,720 12,360
Insurance 608 607
Telephone 569 848
Accountancy 3,194 3,122
Investment management 2,053 2,795
Office Equipment & Computer Maintenance
and Updates 21,216 15,642
40,360 35,374
Total resources expended 292,025 168,536
Net income before gains and losses 16,105 35,455
Realised recognised gains and losses
Realised gains/(losses) on fixed asset investments 319 307
Profit/(loss) on revaluation of investments (26,489) (9,738)
Net (expenditure)/income (10,065) 26,024

This page does not form part of the statutory financial statements

Page 23